feed,title,long_url,short_url
Benzinga,Merck's Keytruda Phase 3 Trial Meets Primary Endpoint In Gastric Cancer Patients,https://benzinga.com/general/biotech/22/11/29822539/mercks-keytruda-phase-3-trial-meets-primary-endpoint-in-gastric-cancer-patients,https://bit.ly/3AANaAm
Benzinga,Graybug Vision Agrees To Merge With Inflammatory Disease-Focused Biopharma,https://benzinga.com/general/biotech/22/11/29820445/graybug-vision-agrees-to-merge-with-inflammatory-disease-focused-biopharma,https://bit.ly/3GxyAgW
